Oral cyclin-dependent kinase 4/6 inhibitor formulated as tablets for targeted cancer therapy. Pharmaceutical manufacturers supply to oncology departments in hospitals and specialized clinics. Distributors procure for chemotherapy regimens in breast cancer treatment protocols across healthcare facilities.